Seino Y, Yabe D, Sasaki T, Fukatsu A, Imazeki H, Ochiai H, et al
Drug exposure The study cohort consisted of new users of GLP-1RAs (dulaglutide, exenatide, liraglutide, lixisenatide or semaglutide), SGLT2 inhibitors (canagliflozin, dapagliflozin or empagliflozin), metformin and other second- or third-line glucose-lowering drugs (thiazolidinediones, dipeptidyl peptidase-4 inhibitors, sulfonylureas, meglitinides, -glucosidase inhibitors, insulin or a combination of glucose-lowering drugs)
Understanding your options and what to expect Delivery timing and how the process works General questions before you decide How Common Is Belching with Ozempic
Ive been yammering on for months(years??) Now it seems like retatrutide seems to increase GFR in patients